The multidrug resistance protein 5 (ABCC5) confers resistance to 5-fluorouracil and transports its monophosphorylated metabolites.
Saved in:
| Title: | The multidrug resistance protein 5 (ABCC5) confers resistance to 5-fluorouracil and transports its monophosphorylated metabolites. |
|---|---|
| Authors: | Pratt S; Cancer Research, Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN 46285, USA., Shepard RL, Kandasamy RA, Johnston PA, Perry W 3rd, Dantzig AH |
| Source: | Molecular cancer therapeutics [Mol Cancer Ther] 2005 May; Vol. 4 (5), pp. 855-63. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print Cited Medium: Print ISSN: 1535-7163 (Print) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 15897250 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The multidrug resistance protein 5 (ABCC5) confers resistance to 5-fluorouracil and transports its monophosphorylated metabolites. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Pratt+S%22">Pratt S</searchLink>; Cancer Research, Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN 46285, USA.<br /><searchLink fieldCode="AU" term="%22Shepard+RL%22">Shepard RL</searchLink><br /><searchLink fieldCode="AU" term="%22Kandasamy+RA%22">Kandasamy RA</searchLink><br /><searchLink fieldCode="AU" term="%22Johnston+PA%22">Johnston PA</searchLink><br /><searchLink fieldCode="AU" term="%22Perry+W+3rd%22">Perry W 3rd</searchLink><br /><searchLink fieldCode="AU" term="%22Dantzig+AH%22">Dantzig AH</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101132535%22">Molecular cancer therapeutics</searchLink> [Mol Cancer Ther] 2005 May; Vol. 4 (5), pp. 855-63. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%2C+Inc%22">American Association for Cancer Research, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101132535 <i>Publication Model: </i>Print <i>Cited Medium: </i>Print <i>ISSN: </i>1535-7163 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215357163%22">15357163 </searchLink><i>NLM ISO Abbreviation: </i>Mol Cancer Ther <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=15897250 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1158/1535-7163.MCT-04-0291 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 855 Titles: – TitleFull: The multidrug resistance protein 5 (ABCC5) confers resistance to 5-fluorouracil and transports its monophosphorylated metabolites. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Pratt S – PersonEntity: Name: NameFull: Shepard RL – PersonEntity: Name: NameFull: Kandasamy RA – PersonEntity: Name: NameFull: Johnston PA – PersonEntity: Name: NameFull: Perry W 3rd – PersonEntity: Name: NameFull: Dantzig AH IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2005 May Type: published Y: 2005 Identifiers: – Type: issn-print Value: 1535-7163 Numbering: – Type: volume Value: 4 – Type: issue Value: 5 Titles: – TitleFull: Molecular cancer therapeutics Type: main |
| ResultId | 1 |
